Crossmark

A ray of hope in the discord: is adding piperacillin–tazobactam to vancomycin truly more nephrotoxic?

Published Online: 2022-08-31

Published Print: 2022-09

Authors

Côté, Jean-Maxime

Kane-Gill, Sandra L.

Murray, Patrick T. https://orcid.org/0000-0001-8516-1839
License Information

Text and Data Mining valid from 2022-08-31

Version of Record valid from 2022-08-31
More Information

Article History

Received: 2 August 2022

Accepted: 4 August 2022

First Online: 31 August 2022

Declarations

:

: J-MC: no conflict of interest. SK-G: Lecturer for CME: American College of Clinical Pharmacy and member of the Executive Board of the Society of Critical Care Medicine. PM: reports consulting fees for Scientific advisory boards for FAST Biomedical and Renibus Therapeutics; Trial Steering Committee for AM-Pharma; Scientific advisory board and Trial Steering Committee for Novartis.

Free to read: This content has been made available to all.

Document is current